Researchers Estimate Number of Nevi Biopsied in U.S. Children

Share this content:
Researchers Estimate Number of Nevi Biopsied in U.S. Children
Researchers Estimate Number of Nevi Biopsied in U.S. Children

(HealthDay News) -- During 2009 through 2013, there were an estimated 2,007,423 biopsies of nevi among children in the United States, according to a research letter published online Dec. 10 in JAMA Dermatology.

Susan A. Oliveria, Sc.D., M.P.H., from the Memorial Sloan Kettering Cancer Center in New York City, and colleagues estimated the number of nevi biopsied in children and adolescents in the United States. Data were obtained from a regional private dermatopathology database from 2009 to 2013, and from a commercial health insurance administrative claims database (the HealthCore Integrated Research Database [HIRD]).

The researchers identified 18,601 surgical specimens in the dermatopathology database from 2009 to 2013, of which 0.09 percent were melanomas, 58.1 percent nevi, and 41.9 percent all other diagnoses. The overall number needed to biopsy to detect one melanoma was 676. During the five-year period, 133,431 biopsies were identified in HIRD, with an estimated 136 melanomas; the number needed to biopsy was 982. Overall, during 2009 through 2013, there were an estimated 2,007,423 biopsies of nevi among individuals aged 19 years and younger; of these 1,940 were melanomas, and the number needed to biopsy was 1,035.

"Understanding the normal evolution of nevi during childhood and adolescence, as well as development of novel noninvasive diagnostic tools, is important in helping to reduce unnecessary biopsies, health care costs, and morbidity in this age group," the authors write.

Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »